Literature DB >> 9266025

Expression of the retinoid-inducible polypeptide, midkine, in human epidermal keratinocytes.

T Inazumi1, S Tajima, T Nishikawa, K Kadomatsu, H Muramatsu, T Muramatsu.   

Abstract

Midkine (MK) is a retinoid-inducible and potent cell growth/differentiation factor active during mouse embryogenesis. We studied MK expression in various cell strains established from the skin. MK and its mRNA were detected in cultured keratinocytes but not in melanoma cell lines or dermal fibroblasts by both Western blot analysis and reverse transcription-polymerase chain reaction (RT-PCR). Treatment of cultured keratinocytes with retinoic acid (10(-5) M, 24 h) resulted in an increase in the level of MK mRNA. When added to cultured keratinocytes, MK stimulated cell proliferation fourfold. Immunohistochemistry revealed MK to be present at the epidermal-dermal junction in embryonic mouse skin and in normal human skin. The limited expression of MK in epidermal keratinocytes indicates that this polypeptide may be involved in the differentiation/proliferation of keratinocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9266025     DOI: 10.1007/s004030050223

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  10 in total

Review 1.  Structure and function of midkine as the basis of its pharmacological effects.

Authors:  T Muramatsu
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 2.  Midkine in host defence.

Authors:  A Gela; S Jovic; S L Nordin; A Egesten
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

3.  FAF and SufA: proteins of Finegoldia magna that modulate the antibacterial activity of histones.

Authors:  Elizabeth C Murphy; Tirthankar Mohanty; Inga-Maria Frick
Journal:  J Innate Immun       Date:  2013-12-11       Impact factor: 7.349

Review 4.  From top to bottom: midkine and pleiotrophin as emerging players in immune regulation.

Authors:  Noah Sorrelle; Adrian T A Dominguez; Rolf A Brekken
Journal:  J Leukoc Biol       Date:  2017-03-29       Impact factor: 4.962

Review 5.  Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target.

Authors:  Panagiota S Filippou; George S Karagiannis; Anastasia Constantinidou
Journal:  Oncogene       Date:  2019-12-04       Impact factor: 9.867

Review 6.  Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases.

Authors:  Takashi Muramatsu
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

Review 7.  Midkine: a promising molecule for drug development to treat diseases of the central nervous system.

Authors:  Takashi Muramatsu
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

8.  Human macrophages and monocyte-derived dendritic cells stimulate the proliferation of endothelial cells through midkine production.

Authors:  Elias A Said; Sumaya Al-Dughaishi; Wadha Al-Hatmi; Iman Al-Reesi; Marwa Al-Riyami; Mohammed S Al-Balushi; Atika Al-Bimani; Juma Z Al-Busaidi; Murtadha Al-Khabori; Salam Al-Kindi; Francesco A Procopio; Afrah Al-Rashdi; Aliyaa Al-Ansari; Hamza Babiker; Crystal Y Koh; Khalid Al-Naamani; Giuseppe Pantaleo; Ali A Al-Jabri
Journal:  PLoS One       Date:  2022-04-27       Impact factor: 3.752

9.  Integration of zebrafish fin regeneration genes with expression data of human tumors in silico uncovers potential novel melanoma markers.

Authors:  Martin Hagedorn; Géraldine Siegfried; Katarzyna B Hooks; Abdel-Majid Khatib
Journal:  Oncotarget       Date:  2016-11-01

Review 10.  Midkine: The Who, What, Where, and When of a Promising Neurotrophic Therapy for Perinatal Brain Injury.

Authors:  Emily Ross-Munro; Faith Kwa; Jenny Kreiner; Madhavi Khore; Suzanne L Miller; Mary Tolcos; Bobbi Fleiss; David W Walker
Journal:  Front Neurol       Date:  2020-10-22       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.